NEW GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS: A COMPREHENSIVE REVIEW

Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a effective class of drugs in the management of type 2 diabetes mellitus. These agents simulate the actions of naturally occurring GLP-1, enhancing insulin secretion and inhibiting glucagon release. Recent investigations have yielded a diverse range of novel GLP-1 receptor agonists w

The United States boasts a considerable number of manufacturers specializing in the production of Tirzepatide APIs. These companies play a essential role in supplying this innovative drug substance to pharmaceutical developers. Tirzepatide, a groundbreaking treatment, has garnered significant acclaim for its effectiveness in managing type 2 diabete